Literature DB >> 15236070

Excretion of trifluoroacetic acid as a metabolite of halothane in digestive juices.

M I Mirkov1, M Morio, M Kawahara, O Yuge, H Kinoshita, K Fujii.   

Abstract

The excretion of trifluoroacetic acid (TFAA) in bile, saliva and gastric juice of two groups of guinea pigs with bile fistulae was measured by ion-chromatography during inhalation of halothane (0.25% and 1.0%) for two hours and after inhalation of halothane. In another two groups without bile fistulae, excretion of TFAA was measured in saliva and gastric juice during and after inhalation of same concentrations of halothane.The excretion of TFAA increased with time and showed the highest concentrations in the saliva. The highest excretion rate and cumulative amounts of excreted TFAA were observed in bile. The cumulative amounts of TFAA excreted into the bile, saliva and gastric juice was 4.85 +/- 1.87 micro mol, 0.89 +/- 0.62 micro mol, 0.11 +/- 0.06 micro mol, respectively, after inhalation of 0.25% halothane and 5.36+/- 2.29 micro mol, 1.50 +/- 0.59 micro mol, 0.25 +/- 0.19 micro mol, respectively, after inhalation of 1.0% halothane. The excretion of TFAA in bile and saliva was saturated after inhalation of the higher concentration of halothane. The excretion of TFAA into the gastric juice was higher with 1.0% concentration of halothane and in animals without bile fistulae. We concluded that TFAA a metabolite of halothane is excreted not only in bile but also in saliva and gastric juice. Biotransformation of halothane in salivary glands seems very likely. A small amount of TFAA excreted in bile enters the enterohepatic circulation. The excretion of TFAA in digestive juice seems to be controlled by a rate-limiting mechanism.

Entities:  

Year:  1988        PMID: 15236070     DOI: 10.1007/s0054080020133

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  10 in total

1.  Aryl hydrocarbon hydroxylase activity in rat submandibular glands.

Authors:  K Murakami; T Ishikawa; T Shimosato; M Noshiro; S Hayashi; K Okuda
Journal:  J Dent Res       Date:  1986-01       Impact factor: 6.116

2.  Volatile metabolites of halothane in the rabbit.

Authors:  S Mukai; M Morior; K Fujii; C Hanaki
Journal:  Anesthesiology       Date:  1977-09       Impact factor: 7.892

3.  Concentration-dependence of halothane metabolism in rabbits.

Authors:  M Okida; H Kikuchi; K Fujii
Journal:  Hiroshima J Med Sci       Date:  1986-03

Review 4.  Metabolism of the volatile anesthetics.

Authors:  E N Cohen
Journal:  Anesthesiology       Date:  1971-08       Impact factor: 7.892

5.  Application of low-temperature autoradiography to studies of the uptake and metabolism of volatile anesthetics in the mouse. 3. Halothane.

Authors:  E N Cohen; N Hood
Journal:  Anesthesiology       Date:  1969-12       Impact factor: 7.892

6.  Differences in the biotransformation of halothane in man.

Authors:  H F Cascorbi; D A Blake; M Helrich
Journal:  Anesthesiology       Date:  1970-02       Impact factor: 7.892

7.  Concentration dependence of hepatic halothane metabolism.

Authors:  D C Sawyer; E I Eger; S H Bahlman; B F Cullen; D Impelman
Journal:  Anesthesiology       Date:  1971-03       Impact factor: 7.892

8.  Urinary metabolites of halothane in man.

Authors:  E N Cohen; J R Trudell; H N Edmunds; E Watson
Journal:  Anesthesiology       Date:  1975-10       Impact factor: 7.892

9.  Effects of exposure concentrations on distribution of halothane metabolites in the body.

Authors:  V Fiserova-Bergerova; R W Kawiecki
Journal:  Drug Metab Dispos       Date:  1984 Jan-Feb       Impact factor: 3.922

10.  Quantitative analysis of trifluoroacetate in the urine and blood by isotachophoresis.

Authors:  M Morio; K Fujii; R Takiyama; F Chikasue; H Kikuchi; L Ribarić
Journal:  Anesthesiology       Date:  1980-07       Impact factor: 7.892

  10 in total
  1 in total

Review 1.  Biotransformation and toxicity of inhalational anaesthetics.

Authors:  M Morio; O Yuge; K Fujii
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.